预灌封注射器填充及完工市场：产业趋势及全球预测 - 依治疗领域、注射器针筒材质、药物分子、业务规模、重点地区

预灌封注射器填充与完工市场：概览

今年全球预灌封注射器填充和完工市场规模达 9.31亿美元。预计在预测期内，该市场将以 11.9%的年复合成长率成长。

市场规模与机会分析依下列参数细分：

治疗领域

• 血液疾病
• 传染病
• 代谢性疾病
• 肿瘤疾病
• 神经系统疾病
• 自体免疫疾病
• 其他

注射器针筒材质

• 玻璃
• 塑胶

针筒腔体数量

• 单腔
• 双腔

药物分子

• 生物製剂
• 小分子

业务尺寸

• 商业化
• 临床前/临床

主要地区

• 北美
• 欧洲
• 亚太地区

预充式注射器填充製造市场：成长与趋势

基本上，预充式注射器是包含预定剂量注射药物的单剂量药物。它们被用作注射药物和疫苗的主要药物容器。装入预充式注射器的药物种类包括血液刺激剂、红血球生成素製剂、干扰素和治疗性蛋白质。在过去十年中，随着肠外给药药物的不断发展，预充式注射器的使用量增加了三倍。值得注意的是，这些预充式注射器与传统给药系统（例如西林瓶和注射器）相比具有许多优势，包括降低给药错误的可能性、提高患者依从性以及降低微生物污染的风险。因此，预充式注射器是注射药物输送的首选，尤其是在治疗慢性疾病（需要重复给药）方面。

预充式注射器的众多优势，加上日益成长的自我用药趋势，促使许多药物与此类装置联合使用获得批准，导致对灌装/灌装业务外包的需求增加。此外，由于许多营运挑战，例如需要密切监控和管理注射器填充量所需的技术专长，市场正见证着预先填充注射器填充和完工业务外包的趋势。此外，目前对更安全、更便捷的给药技术的需求，以及业界为降低成本和提高效率所做的努力，预计将在未来几年推动预灌装注射器灌装和完工製造市场的成长。

预灌註注射器填充与完工市场：关键洞察

本报告深入探讨了全球预先填充注射器填充和完工製造市场的现状，并识别了行业内的潜在成长机会。报告的主要调查结果包括：

• 全球有超过 100 家公司声称提供预先填充注射器合约填充和完工服务，其中近 50%的服务提供者是拥有 500 多名员工的大型公司。
• 市场格局的特点是，该领域涌现出众多知名公司，其中许多公司声称业务规模各异，且分布在不同的地区。
• 超过 55%的公司同时提供小分子药物和生物製剂的填充服务，约20%的公司致力于生物製剂。
• 不同规模和地区的公司纷纷加入，目的是提升整个供应链的竞争力，并满足客户不断变化的需求。

• 多家合约服务供应商（约60家公司）提供临床和商业规模的灌装/完成服务，包括AMRI、Catalent Biologics、Pierre Fabrre和Sandoz。
• 虽然大多数产业利害关係人位于已开发国家，但灌装/完成业务印度、台湾和孟加拉等亚洲国家/地区兴起。
• 灌装/完成服务提供者积极投资扩建项目，以升级其现有产能。
• 如预期的那样，大多数预灌封注射器灌装/完成合约设施都属于大型服务供应商，约占全球可用设施的80%。
• 对预充式注射器组合产品开发商的评估显示，欧洲和北美是灌装/封口服务提供者合作机会的关键地区。
• 约有70种预充式注射器由大型公司生产，其中大多数公司声称能够生产玻璃和塑胶材质的注射器针筒。
• 短期至中期内，预计药品开发商将灌装/封口业务外包的情况将持续，合约服务市场的年成长率将超过11.9%。
• 从长远来看，预计预充式注射器填充/封口服务提供者的机会可能会在不同类型的针筒、业务规模和地理区域方面呈现高度多样化。

• 随着预充式注射器需求的不断成长以及对用户友善型系统的关注，预计未来几年市场机会将快速发展。

预充式注射器填充製造市场的参与者

• Ajinomoto Bio-Pharma Services
• AMRI
• BioPharma Solutions
• Emergent BioSolutions
• Patheon（a Thermo Fisher Scientific Company）
• Consort Medical
• EVER Pharma
• GlaxoSmithKline
• IDT Biologika
• Rentschler Biopharma
• Siegfried
• Vetter Pharma
• Biocon
• Intas Pharmaceuticals
• Kemwell Biopharma
• Square Pharmaceuticals.

目录

第1章 简介

第2章 执行摘要

第3章 简介

• 章节概述
• 预灌封注射器简介
• 预灌封注射器的填充和完工过程
• 预灌封注射器填充和完工市场的成长因素
• 无菌注射剂填充和完工业务外包的需求
• 灌装和完工服务外包的优势
• 灌装和完工业务外包的风险
• 选择灌装和完工服务提供者时需要考虑的重要事项

第4章 市场市场格局

• 章节概述
• 预灌封注射器填充和完工服务提供者：市场格局

第5章 北美预灌封注射器灌装和完工服务提供者：公司简介

• 章节概述
• Ajinomoto Bio-Pharma Services
• AMRI
• BioPharma Solutions
• Emergent BioSolutions
• Patheon

第6章 欧洲预灌封注射器灌装和完工服务提供者：公司简介

• 章节概述
• Consort Medical
• EVER Pharma
• GlaxoSmithKline
• IDT Biologika
• Rentschler Biopharma
• Siegfried
• Vetter Pharma

第7章 亚太地区预灌封注射器填充和完工服务提供者：公司简介

• 章节概述
• Biocon
• Intas Pharmaceuticals
• Kemwell Biopharma
• Square Pharmaceuticals

第8章 预灌封注射器灌装完工服务提供者：最新发展

• 章节概述
• 扩充列表
• 合作模式
• 合作与合作清单

第9章 产能分析

第10章 需求分析

第11章 供需地理评估

• 章节概述
• 假设和关键参数
• 北美供需评估
• 欧洲供需评估
• 亚太地区供需评估

第12章 潜在伙伴分析

第13章 市场规模评估与机会分析

• 章节概述
• 预测研究方法与关键假设
• 预灌封注射器填充服务市场（至2035）

第14章 未来成长机会

• 章节概述
• 不断成长的注射剂药物产品线
• 预灌封注射器日益普及
• 外包灌装作业的偏好日益增加
• 无菌填充技术的进步
• 亚太地区的成长机会

第15章 案例研究：预灌封注射器製造商

• 章节概述
• 预充式注射器：现有/在研器械列表
• 预充式注射器：製造商列表

第16章 结论

第17章 访谈纪录

第18章 附录1：表格资料

第19章 附录2：公司列表

PREFILLED SYRINGE FILL FINISH MANUFACTURING MARKET: OVERVIEW

As per Roots Analysis, the global prefilled syringe fill finish manufacturing market valued at USD 931 million in the current year is anticipated to grow at a lucrative CAGR of 11.9% during the forecast period.

The market sizing and opportunity analysis has been segmented across the following parameters:

Type of Therapeutic Area

• Blood Disorders
• Infectious Diseases
• Metabolic Disorders
• Oncology Disorders
• Neurological Disorders
• Autoimmune Disorders
• Others

Type of Syringe Barrel Material

• Glass
• Plastic

Number of Barrel Chambers

• Single Chamber
• Dual Chamber

Type of Drug Molecule

• Biologic
• Small Molecule

Scale of Operation

• Commercial
• Preclinical / Clinical

Key Geographical Regions

• North America
• Europe
• Asia- Pacific

PREFILLED SYRINGE FILL FINISH MANUFACTURING MARKET: GROWTH AND TRENDS

Fundamentally, a prefilled syringe is a single dose of medication, containing a pre-measured amount of injectable. It is used as a primary drug container for injectable drugs and vaccines. Some of the categories of drugs packaged in prefilled syringes include blood stimulants, erythropoietin products, interferons and therapeutic proteins. Over the past ten years, with the increase in development of parenteral drugs, the usage of prefilled syringes has tripled. Notably, these prefilled syringes offer several advantages over traditional drug delivery systems (such as vials and syringes), including reduced chances of dosing errors, increased patient compliance and decreased risk of microbial contamination. As a result, prefilled syringes are preferably being used in the delivery of injectable drugs, especially in the treatment of chronic diseases (requiring repeated administration of the medications).

The numerous benefits offered by prefilled syringes, coupled with the growing self-medication trend, have led to the approval of a number of drugs in combination with such devices, resulting in an increase in need to outsource fill / finish operations. Moreover, owing to a number of operational challenges, such as the requirement of technical expertise associated with close monitoring and control of syringe fill volume, the market has witnessed a shift in trend towards outsourcing of the fill / finish operations for prefilled syringes. Additionally, the current demand for safer, easier to use administration technologies along with the industry's efforts to reduce costs and increase efficiency are expected to drive the growth of the prefilled syringe fill finish manufacturing market in future.

PREFILLED SYRINGE FILL FINISH MANUFACTURING MARKET: KEY INSIGHTS

The report delves into the current state of the global prefilled syringe fill finish manufacturing market and identifies potential growth opportunities within industry. Some key findings from the report include:

• Over 100 companies across the globe claim to provide contract fill / finish services for prefilled syringes; close to 50% of these service providers are large companies with over 500 employees.
• The market landscape features the presence of well-established players in the domain, most of which claim to operate at various scales of operation and are located in different geographies.
• Over 55% of the companies have the capabilities to offer fill / finish services for both small molecules and biologics; ~20% of the companies are offering these services for only biologics.
• In order to acquire competencies across the supply chain and cater to the evolving needs of clients, companies offering services across different scales of operation have established presence in various geographies.

• Several contract service providers (~60), including AMRI, Catalent Biologics, Pierre Fabrre and Sandoz offer fill / finish services at both clinical and commercial scale of operation.
• Although most industry stakeholders are based in the developed regions, fill / finish operations in Asian countries, such as India, Taiwan and Bangladesh, are emerging.
• Fill / finish service providers are actively investing in expansion projects to upgrade existing capabilities and capacity; several partnerships, mostly focused on offering contract services, have also been forged.
• As expected, majority of the installed contract fill / finish capacity for prefilled syringes belongs to the large service providers, accounting for around 80% of the available global capacity.
• An evaluation of prefilled syringe combination product developers revealed that Europe and North America have emerged as the key regions for partnering opportunities for fill / finish service providers.
• Around 70 prefilled syringes are being manufactured by large companies, most of which claim to be capable of fabricating syringe barrels from both glass and plastic materials.
• We expect drug developers to continue to outsource their fill / finish operations in the short to midterm, resulting in an annualized growth at the rate of over 11.9% within the contract services market.
• In the long-term, the projected opportunity for the fill / finish service providers for prefilled syringes is likely to be well distributed across various types of barrel chambers, scales of operation and geographical regions.

• With an increasing demand for prefilled syringes and focus on user-friendly systems, the market opportunity is projected to evolve at a rapid pace in the coming years.

Example Players in the Prefilled Syringe Fill Finish Manufacturing Market

• Ajinomoto Bio-Pharma Services
• AMRI
• BioPharma Solutions
• Emergent BioSolutions
• Patheon (a Thermo Fisher Scientific Company)
• Consort Medical
• EVER Pharma
• GlaxoSmithKline
• IDT Biologika
• Rentschler Biopharma
• Siegfried
• Vetter Pharma
• Biocon
• Intas Pharmaceuticals
• Kemwell Biopharma
• Square Pharmaceuticals.

PREFILLED SYRINGE FILL FINISH MANUFACTURING MARKET: RESEARCH COVERAGE

• Market Sizing and Opportunity Analysis: The report features an in-depth analysis of the prefilled syringe fill finish manufacturing market, focusing on key market segments, including [A] type of therapeutic area, [B] type of syringe barrel material, [C] number of barrel chambers, [D] type of drug molecule, [E] scale of operation and [F] key geographical regions.
• Market Landscape: A comprehensive evaluation of companies offering contract fill / finish services for prefilled syringes, based on several relevant parameters, such as [A] year of establishment, [B] company size, [C] scale of operation, [D] location of the headquarters, [E] location of fill / finish facilities, [F] type of drug molecule, [G] syringe barrel material, [H] syringe fill volume and additional services offered and [I] installed capacity.
• Company Profiles: In-depth profiles of the players engaged in this domain, focusing on [A] overview of the company, [B] financial information (if available), [C] service portfolio, [D] fill / finish facilities and [E] recent developments and an informed future outlook.
• Recent Developments: A comprehensive competitive analysis of recent developments pertaining to contract fill / finish services, based on various parameters, such as [A] year of development, [B] type of activity / development, [C] scale of operation of the project, [D] location of expanded facility, [E] type of drug molecule involved and [F] additional services offered.
• Capacity Analysis: An in-depth analysis of contract fill / finish capacity of prefilled syringes, examining factors, such as [A] company size of manufacturer, [B] scale of operation, [C] location of headquarters and fill / finish facilities and [D] type of drug molecule.
• Demand Analysis: A detailed analysis of the current and future demand for fill / finish of prefilled syringes, based on various parameters, such as [A] marketed drugs available, [B] target patient population, [C] dosing frequency, [D] dose strength, [E] geography, [F] type of drug molecule, [G] therapeutic area, [H] syringe barrel material and [I] number of barrel chambers.
• Geographical Assessment of Demand and Supply: An insightful geographical analysis of demand and supply, based on several parameters, such as [A] number of prefilled syringe combination product developers, [B] number of prefilled syringe manufacturers, [C] number of prefilled syringe fill / finish service providers, [D] number of prefilled syringe fill / finish facilities, and [E] capacity and demand for prefilled syringes in that particular geographical region.
• Likely Partner Analysis: A detailed analysis of the potential strategic partners for prefilled syringe fill / finish service providers, based on various parameters, such as [A] developer strength, [B] pipeline strength, [C] type of drug molecule, [D] target therapeutic area and [E] location of the headquarters of the company.
• Case Study 1: A detailed discussion on the potential areas of growth, such as [A] growing injectable drugs pipeline, [B] increasing popularity of prefilled syringes, [C] rise in preference for outsourcing of fill / finish operations, [D] technological advancements in aseptic fill / finish processes and [E] growing opportunities in the Asia-Pacific region.
• Case Study 2: Elaborate assessment of prefilled syringe manufacturers landscape, based on a number of relevant parameters, such as [A] syringe barrel material, [B] number of barrel chambers, [C] type of needle system, [D] barrel volume, [E] year of establishment and [F] location of the headquarters of manufacturers.

KEY QUESTIONS ANSWERED IN THIS REPORT

• How many companies are currently engaged in this market?
• Which are the leading companies in this market?
• What factors are likely to influence the evolution of this market?
• What is the current and future market size?
• What is the CAGR of this market?
• How is the current and future market opportunity likely to be distributed across key market segments?

REASONS TO BUY THIS REPORT

• The report provides a comprehensive market analysis, offering detailed revenue projections of the overall market and its specific sub-segments. This information is valuable to both established market leaders and emerging entrants.
• Stakeholders can leverage the report to gain a deeper understanding of the competitive dynamics within the market. By analyzing the competitive landscape, businesses can make informed decisions to optimize their market positioning and develop effective go-to-market strategies.
• The report offers stakeholders a comprehensive overview of the market, including key drivers, barriers, opportunities, and challenges. This information empowers stakeholders to stay abreast of market trends and make data-driven decisions to capitalize on growth prospects.

ADDITIONAL BENEFITS

• Complimentary PPT Insights Packs
• Complimentary Excel Data Packs for all Analytical Modules in the Report
• 15% Free Content Customization
• Detailed Report Walkthrough Session with Research Team
• Free Updated report if the report is 6-12 months old or older

TABLE OF CONTENTS

1. PREFACE

• 1.1. Scope of the Report
• 1.2. Research Methodology
  • 1.2.1. Research Assumptions
  • 1.2.2. Project Methodology
  • 1.2.3. Forecast Methodology
  • 1.2.4. Robust Quality Control
  • 1.2.5. Key Considerations
    • 1.2.5.1. Demographics
    • 1.2.5.2. Economic Factors
    • 1.2.5.3. Government Regulations
    • 1.2.5.4. Supply Chain
    • 1.2.5.5. COVID Impact / Related Factors
    • 1.2.5.6. Market Access
    • 1.2.5.7. Healthcare Policies
    • 1.2.5.8. Industry Consolidation
• 1.3 Key Questions Answered
• 1.4. Chapter Outlines

2. EXECUTIVE SUMMARY

3. INTRODUCTION

• 3.1. Chapter Overview
• 3.2. Introduction to Prefilled Syringes
  • 3.2.1. Classification of Prefilled Syringes
  • 3.2.2. Manufacturing of Prefilled Syringes
  • 3.2.3. Advantages of Prefilled Syringes
    • 3.2.3.1. Benefits to Healthcare Professionals and End Users
    • 3.2.3.2. Benefits to Manufacturers
• 3.3. Fill / Finish Processing of Prefilled Syringes
  • 3.3.1. Steps Involved in Fill / Finish Process
  • 3.3.2. Methods of Filling and Stoppering of Prefilled Syringes
  • 3.3.3. Prefilled Syringe Filling Technologies
• 3.4. Factors Contributing to the Growth of Prefilled Syringe Fill / Finish Market
• 3.5. Need for Outsourcing Fill / Finish Operations of Sterile Injectables
• 3.6. Advantages of Outsourcing Fill / Finish Services
• 3.7. Risks Associated with Outsourcing of Fill / Finish Operations
• 3.8. Key Considerations While Selecting a Fill / Finish Service Provider

4. MARKET LANDSCAPE

• 4.1. Chapter Overview
• 4.2. Prefilled Syringe Fill / Finish Service Providers: Overall Market Landscape
  • 4.2.1. Analysis by Year of Establishment
  • 4.2.2. Analysis by Company Size
  • 4.2.3. Analysis by Scale of Operation
  • 4.2.4. Analysis by Location of Headquarters
  • 4.2.5. Analysis by Location of Prefilled Syringe Fill / Finish Facilities
  • 4.2.6. Analysis by Type of Drug Molecule
  • 4.2.7. Analysis by Syringe Barrel Material
  • 4.2.8. Analysis by Syringe Fill Volume
  • 4.2.9. Analysis by Additional Services Offered
  • 4.2.10. Heat Map: Analysis by Company Size and Location of Headquarters
  • 4.2.11. Logo Landscape: Analysis by Company Size and Type of Drug Molecule
  • 4.2.12. Geographical Map: Analysis by Scale of Operation and Location of Fill / Finish Facilities
  • 4.2.13. Grid Representation: Distribution by Year of Establishment, Company Size and Type of Drug Molecule

5. PREFILLED SYRINGE FILL / FINISH SERVICE PROVIDERS IN NORTH AMERICA: COMPANY PROFILES

• 5.1. Chapter Overview
• 5.2. Ajinomoto Bio-Pharma Services
  • 5.2.1. Company Overview
  • 5.2.2. Recent Developments and Future Outlook
• 5.3. AMRI
  • 5.3.1. Company Overview
  • 5.3.2. Recent Developments and Future Outlook
• 5.4. BioPharma Solutions
  • 5.4.1. Company Overview
  • 5.4.2. Recent Developments and Future Outlook
• 5.5. Emergent BioSolutions
  • 5.5.1. Company Overview
  • 5.5.2. Recent Developments and Future Outlook
• 5.6. Patheon (a Thermo Fisher Scientific Company)
  • 5.6.1. Company Overview
  • 5.6.2. Recent Developments and Future Outlook

6. PREFILLED SYRINGE FILL / FINISH SERVICE PROVIDERS IN EUROPE: COMPANY PROFILES

• 6.1. Chapter Overview
• 6.2. Consort Medical
  • 6.2.1. Company Overview
  • 6.2.2. Recent Developments and Future Outlook
• 6.3. EVER Pharma
  • 6.3.1. Company Overview
  • 6.3.2. Recent Developments and Future Outlook
• 6.4. GlaxoSmithKline
  • 6.4.1. Company Overview
  • 6.4.2. Recent Developments and Future Outlook
• 6.5. IDT Biologika
  • 6.5.1. Company Overview
  • 6.5.2. Recent Developments and Future Outlook
• 6.6. Rentschler Biopharma
  • 6.6.1. Company Overview
  • 6.6.2. Recent Developments and Future Outlook
• 6.7. Siegfried
  • 6.7.1. Company Overview
  • 6.7.2. Recent Developments and Future Outlook
• 6.8. Vetter Pharma
  • 6.8.1. Company Overview
  • 6.8.2. Recent Developments and Future Outlook

7. PREFILLED SYRINGE FILL / FINISH SERVICE PROVIDERS IN ASIA-PACIFIC: COMPANY PROFILES

• 7.1. Chapter Overview
• 7.2. Biocon
  • 7.2.1. Company Overview
  • 7.2.2. Recent Developments and Future Outlook
• 7.3. Intas Pharmaceuticals
  • 7.3.1. Company Overview
  • 7.3.2. Recent Developments and Future Outlook
• 7.4. Kemwell Biopharma
  • 7.4.1. Company Overview
  • 7.4.2. Recent Developments and Future Outlook
• 7.5. Square Pharmaceuticals
  • 7.5.1. Company Overview
  • 7.5.2. Recent Developments and Future Outlook

8. PREFILLED SYRINGE FILL / FINISH SERVICE PROVIDERS: RECENT DEVELOPMENTS

• 8.1. Chapter Overview
• 8.2. List of Expansions
  • 8.2.1. Analysis by Year of Expansion
  • 8.2.2. Analysis by Type of Expansion
  • 8.2.3. Analysis by Expanded Scale of Operation
  • 8.2.4. Analysis by Location of Expansion Project
  • 8.2.5. Analysis by Type of Drug Molecule Involved
  • 8.2.6. Analysis by Additional Services Offered (Expansion Specific)
• 8.3. Partnership Models
• 8.4. List of Partnerships and Collaborations
  • 8.4.1. Analysis by Year of Partnership
  • 8.4.2. Analysis by Type of Partnership
  • 8.4.3. Analysis by Scale of Operation (Deal Specific)
  • 8.4.4. Analysis by Additional Services Offered (Deal Specific)

9. CAPACITY ANALYSIS

• 9.1. Chapter Overview
• 9.2. Assumptions and Methodology
• 9.3. Global, Prefilled Syringe Fill / Finish Capacity (by Number of Units)
  • 9.3.1. Analysis by Company Size
  • 9.3.2. Analysis by Scale of Operation
  • 9.3.3. Analysis by Location of Headquarters
  • 9.3.4. Analysis by Location of Fill / Finish Facilities
  • 9.3.5. Analysis by Type of Drug Molecule
• 9.4. Global, Prefilled Syringe Fill / Finish Capacity (by Volume)
  • 9.4.1. Analysis by Company Size (Manufacturer)
  • 9.4.2. Analysis by Scale of Operation
  • 9.4.3. Analysis by Location of Headquarters
  • 9.4.4. Analysis by Location of Fill / Finish Facilities
  • 9.4.5. Analysis by Type of Drug Molecule

10. DEMAND ANALYSIS

• 10.1. Chapter Overview
• 10.2. Assumptions and Methodology
• 10.3. Global Demand for Prefilled Syringes Fill / Finish Services
  • 10.3.1. Global Demand for Commercialized Prefilled Syringes Fill / Finish Services
    • 10.3.1.1. Analysis by Geography
      • 10.3.1.1.1. North America
      • 10.3.1.1.2. Europe
      • 10.3.1.1.3. Asia-Pacific
      • 10.3.1.1.4. Latin America
      • 10.3.1.1.5. Middle East and Africa
    • 10.3.1.2. Analysis by Syringe Barrel Material
    • 10.3.1.3. Analysis by Number of Barrel Chambers
    • 10.3.1.4. Analysis by Type of Drug Molecule
    • 10.3.1.5. Analysis by Therapeutic Area
    • 10.3.1.6. Analysis by Specialty Syringes
  • 10.3.2. Global Demand for Clinical Prefilled Syringes Fill / Finish Services
• 10.4. Demand and Supply Analysis
  • 10.4.1. Demand and Supply Analysis (Scenario 1)
  • 10.4.2. Demand and Supply Analysis (Scenario 2)
  • 10.4.3. Demand and Supply Analysis (Scenario 3)

11. GEOGRAPHICAL ASSESSMENT OF DEMAND AND SUPPLY

• 11.1. Chapter Overview
• 11.2. Assumptions and Key Parameters
• 11.3. Demand and Supply Assessment in North America
  • 11.3.1. Key Geographies
    • 11.3.1.1. US
• 11.4. Demand and Supply Assessment in Europe
  • 11.4.1. Key Geographies
    • 11.4.1.1. France
    • 11.4.1.2. Germany
    • 11.4.1.3. Italy
• 11.5. Demand and Supply Assessment in Asia-Pacific Region
  • 11.5.1. Key Geographies
    • 11.5.1.1. India
    • 11.5.1.2. Japan

12. LIKELY PARTNER ANALYSIS

• 12.1. Chapter Overview
• 12.2. Methodology and Key Parameters
• 12.3. Likely Partner Analysis
  • 12.3.1. Opportunities in North America
    • 12.3.1.1. Most Likely Partners for Prefilled Syringe Fill / Finish Service Providers
    • 12.3.1.2. Likely Partners for Prefilled Syringe Fill / Finish Service Providers
  • 12.3.2. Opportunities in Europe
    • 12.3.2.1. Most Likely Partners for Prefilled Syringe Fill / Finish Service Providers
    • 12.3.2.2. Likely Partners for Prefilled Syringe Fill / Finish Service Providers
  • 12.3.3. Opportunities in Asia-Pacific and Rest of the World
    • 12.3.3.1. Most Likely Partners for Prefilled Syringe Fill / Finish Service Providers
    • 12.3.3.2. Likely Partners for Prefilled Syringe Fill / Finish Service Providers

13. MARKET SIZING AND OPPORTUNITY ANALYSIS

• 13.1. Chapter Overview
• 13.2. Forecast Methodology and Key Assumptions
• 13.3. Overall Prefilled Syringe Fill / Finish Services Market, Till 2035
  • 13.3.1. Prefilled Syringe Fill / Finish Services Market: Distribution by Scale of Operation, Till 2035
  • 13.3.2. Prefilled Syringe Fill / Finish Services Market: Distribution by Geographical Region
    • 13.3.2.1. Prefilled Syringe Fill / Finish Services Market in North America
    • 13.3.2.2. Prefilled Syringe Fill / Finish Services Market in Europe
    • 13.3.2.3. Prefilled Syringe Fill / Finish Services Market in Asia-Pacific
    • 13.3.2.4. Prefilled Syringe Fill / Finish Services Market Latin America
    • 13.3.2.5. Prefilled Syringe Fill / Finish Services Market in Middle East and Africa
  • 13.3.3. Prefilled Syringe Fill / Finish Services Market: Distribution by Type of Drug Molecule, Till 2035
  • 13.3.4. Prefilled Syringe Fill / Finish Services Market: Distribution by Therapeutic Area
  • 13.3.5. Prefilled Syringe Fill / Finish Services Market: Distribution by Syringe Barrel Material, Till 2035
  • 13.3.6. Prefilled Syringe Fill / Finish Services Market: Distribution by Number of Barrel Chambers, Till 2035

14. FUTURE GROWTH OPPORTUNITIES

• 14.1. Chapter Overview
• 14.2. Growing Injectable Drugs Pipeline
• 14.3. Increase in Popularity of Prefilled Syringes
• 14.4. Rise in Preference for Outsourcing Fill / Finish Activities
• 14.5. Advances in Aseptic Fill / Finish Technologies
• 14.6. Growing Opportunities in the Asia-Pacific Region

15. CASE STUDY: PREFILLED SYRINGE MANUFACTURERS

• 15.1. Chapter Overview
• 15.2. Prefilled Syringes: List of Available / Under Development Devices
  • 15.2.1. Analysis by Syringe Barrel Material
  • 15.2.2. Analysis by Number of Barrel Chambers
  • 15.2.3. Analysis by Type of Needle System
  • 15.2.4. Analysis by Barrel Volume
• 15.3. Prefilled Syringes: List of Manufacturers
  • 15.3.1. Analysis by Year of Establishment
  • 15.3.2. Analysis by Location of Headquarters

16. CONCLUDING REMARKS

• 16.1. Chapter Overview
• 16.2. Key Takeaways

17. INTERVIEW TRANSCRIPTS

• 17.1. Chapter Overview
• 17.2. Company A
  • 17.2.1. Company Snapshot
  • 17.2.2. Interview Transcript: President and Cofounder
• 17.3. Company B
  • 17.3.1. Company Snapshot
  • 17.3.2. Interview Transcript: Chief Technical Officer
• 17.4. Company C
  • 17.4.1. Company Snapshot
  • 17.4.2. Interview Transcript: Chief Commercial Officer
• 17.5. Company D
  • 17.5.1. Company Snapshot
  • 17.5.2. Interview Transcript: Associate Director, Head of Process Sciences Formulation and Fill / Finish
• 17.6. Company E
  • 17.6.1. Company Snapshot
  • 17.6.2. Interview Transcript: Research Director and Head of Formulation Development
• 17.7. Company F
  • 17.7.1. Company Snapshot
  • 17.7.2. Interview Transcript: Design Director

18. APPENDIX 1: TABULATED DATA

19. APPENDIX 2: LIST OF COMPANIES

List of Tables

• Table 3.1 Classification of Prefilled Syringes
• Table 4.1 Prefilled Syringe Fill / Finish Service Providers: List of Companies
• Table 4.2 Prefilled Syringe Fill / Finish Service Providers: Information on Location of Fill / Finish Facilities
• Table 4.3 Prefilled Syringe Fill / Finish Service Providers: Information on Type of Drug Molecule
• Table 4.4 Prefilled Syringe Fill / Finish Service Providers: Information on Syringe Barrel Material
• Table 4.5 Prefilled Syringe Fill / Finish Service Providers: Information on Syringe Fill Volume Range
• Table 4.6 Prefilled Syringe Fill / Finish Service Providers: Information on Additional Services Offered
• Table 4.7 Prefilled Syringe Fill / Finish Service Providers: Distribution by Company Size and Location of Headquarters
• Table 4.8 Prefilled Syringe Fill / Finish Service Providers: Information on Fill / Finish Capability
• Table 5.1 Prefilled Syringes Fill / Finish Service Providers in North America: List of Profiled Companies
• Table 5.2 Ajinomoto Bio-Pharma Services: Company Snapshot
• Table 5.3 Ajinomoto Bio-Pharma Services: Recent Developments and Future Outlook
• Table 5.4 AMRI: Company Snapshot
• Table 5.5 AMRI: Recent Developments and Future Outlook
• Table 5.6 BioPharma Solutions: Company Snapshot
• Table 5.7 BioPharma Solutions: Recent Developments and Future Outlook
• Table 5.8 Emergent BioSolutions: Company Snapshot
• Table 5.9 Emergent BioSolutions: Recent Developments and Future Outlook
• Table 5.10 Patheon: Company Snapshot
• Table 5.11 Patheon: Recent Developments and Future Outlook
• Table 6.1 Prefilled Syringe Fill / Finish Service Providers in Europe: List of Profiled Companies
• Table 6.2 Consort Medical: Company Snapshot
• Table 6.3 Consort Medical: Recent Developments and Future Outlook
• Table 6.4 EVER Pharma: Company Snapshot
• Table 6.5 EVER Pharma: Recent Developments and Future Outlook
• Table 6.6 GlaxoSmithKline: Company Snapshot
• Table 6.7 GlaxoSmithKline: Recent Developments and Future Outlook
• Table 6.8 IDT Biologika: Company Snapshot
• Table 6.9 IDT Biologika: Recent Developments and Future Outlook
• Table 6.10 Rentschler Biopharma: Company Snapshot
• Table 6.11 Rentschler Biopharma: Recent Developments and Future Outlook
• Table 6.12 Siegfried: Company Snapshot
• Table 6.13 Siegfried: Recent Developments and Future Outlook
• Table 6.14 Vetter Pharma: Company Snapshot
• Table 6.15 Vetter Pharma: Recent Developments and Future Outlook
• Table 7.1 Prefilled Syringes Fill / Finish Service Providers in Asia-Pacific: List of Profiled Companies
• Table 7.2 Biocon: Company Snapshot
• Table 7.3 Biocon: Recent Developments and Future Outlook
• Table 7.4 Intas Pharmaceuticals: Company Snapshot
• Table 7.5 Intas Pharmaceuticals: Recent Developments and Future Outlook
• Table 7.6 Kemwell Biopharma: Company Snapshot
• Table 7.7 Kemwell Biopharma: Recent Developments and Future Outlook
• Table 7.8 Square Pharmaceuticals: Company Snapshot
• Table 7.9 Square Pharmaceuticals: Recent Developments and Future Outlook
• Table 8.1 Prefilled Syringe Fill / Finish Service Providers: Recent Expansions, Since 2015
• Table 8.2 Expansions: Information on Additional Services Offered
• Table 8.3 Prefilled Syringe Fill / Finish Service Providers: Partnerships and Collaborations, Since 2015
• Table 8.4 Partnerships: Information on Type of Services
• Table 9.1 Global, Prefilled Syringe Fill / Finish Capacity (by Number of Units): Average Capacity by Company Size (Sample Data Set)
• Table 10.1 Global Prefilled Syringe Fill / Finish Services Annual Supply, Till 2035 (Million Units)
• Table 10.2 Global Annual Outsourcing Demand for Prefilled Syringe Fill / Finish Services (Million Units)
• Table 10.3 Global Annual Outsourcing Demand for Prefilled Syringe Fill / Finish Services (Million Units)
• Table 10.4 Global Annual Outsourcing Demand for Prefilled Syringe Fill / Finish Services (Million Units)
• Table 11.1 Demand and Supply Assessment: North America
• Table 11.2 Demand and Supply Assessment: Europe
• Table 11.3 Demand and Supply Assessment: Asia-Pacific
• Table 12.1 Opportunities in North America: Most Likely Partners for Prefilled Syringe Fill / Finish Service Providers
• Table 12.2 Opportunities in North America: Likely Partners for Prefilled Syringe Fill / Finish Service Providers
• Table 12.3 Opportunities in Europe: Most Likely Partners for Prefilled Syringe Fill / Finish Service Providers
• Table 12.4 Opportunities in Europe: Likely Partners for Prefilled Syringe Fill / Finish Service Providers
• Table 12.5 Opportunities in Asia-Pacific and Rest of the World: Most Likely Partners for Prefilled Syringe Fill / Finish Service Providers
• Table 12.6 Opportunities in Asia-Pacific and Rest of the World: Likely Partners for Prefilled Syringe Fill / Finish Service Providers
• Table 14.1 List of Pharmaceutical Robotics Manufacturers
• Table 14.2 List of Companies Supplying Ready-to-Use Packaging Components
• Table 14.3 Patent Expiry of Biologics, Since 2018
• Table 15.1 Prefilled Syringes: List of Available / Under Development Devices
• Table 15.2 Prefilled Syringes: List of Manufacturers
• Table 16.1 Prefilled Syringe Fill / Finish Services Market: Key Takeaways
• Table 17.1 Bio Elpida: Key Highlights
• Table 17.2 Intas Pharmaceuticals: Key Highlights
• Table 17.3 IDT Biologika: Key Highlights
• Table 17.4 Takeda: Key Highlights
• Table 17.5 Syngene: Key Highlights
• Table 17.6 IDEO: Key Highlights
• Table 18.1 Prefilled Syringe Fill / Finish Service Providers: Distribution by Year of Establishment
• Table 18.2 Prefilled Syringe Fill / Finish Service Providers: Distribution by Company Size
• Table 18.3 Prefilled Syringe Fill / Finish Service Providers: Distribution by Scale of Operation
• Table 18.4 Prefilled Syringe Fill / Finish Service Providers: Distribution by Location of Headquarters
• Table 18.5 Prefilled Syringe Fill / Finish Service Providers: Distribution by Location of Fill / Finish Facilities
• Table 18.6 Prefilled Syringe Fill / Finish Service Providers: Distribution by Company Size and Type of Drug Molecule
• Table 18.7 Prefilled Syringe Fill / Finish Service Providers: Distribution by Syringe Barrel Material
• Table 18.8 Prefilled Syringe Fill / Finish Service Providers: Distribution by Syringe Fill Volume
• Table 18.9 Prefilled Syringe Fill / Finish Service Providers: Distribution by Additional Services Offered
• Table 18.10 Partnerships and Collaborations: Distribution by Year of Partnership, Since 2015
• Table 18.11 Partnerships and Collaborations: Distribution by Type of Partnership
• Table 18.12 Partnerships and Collaborations: Distribution by Scale of Operation (Deal Specific)
• Table 18.13 Partnerships and Collaborations: Distribution by Additional Services Offered (Deal Specific)
• Table 18.14 Most Active Players: Distribution by Number of Partnerships
• Table 18.15 Expansions: Distribution by Year of Expansion, Since 2015
• Table 18.16 Expansions: Distribution by Type of Expansion
• Table 18.17 Expansions: Distribution by Expanded Scale of Operation
• Table 18.18 Expansions: Distribution by Location of Expansion Project
• Table 18.19 Expansions: Distribution by Type of Drug Molecule Involved
• Table 18.20 Expansions: Distribution by Additional Services Offered (Expansion Specific)
• Table 18.21 Global, Prefilled Syringe Fill / Finish Capacity: Distribution of Capacity by Size of Manufacturer (Sample Data Set)
• Table 18.22 Global, Prefilled Syringe Fill / Finish Capacity: Distribution by Company Size of Manufacturer (in Million Units)
• Table 18.23 Global, Prefilled Syringe Fill / Finish Capacity (by Number of Units): Distribution by Scale of Operation (in Million Units)
• Table 18.24 Global, Prefilled Syringe Fill / Finish Capacity (by Number of Units): Distribution by Location of Headquarters (in Million Units)
• Table 18.25 Global, Prefilled Syringe Fill / Finish Capacity (by Number of Units): Distribution by Location of Fill / Finish Facilities (in Million Units)
• Table 18.26 Global, Prefilled Syringe Fill / Finish Capacity (by Number of Units): Distribution by Type of Drug Molecule (in Million Units)
• Table 18.27 Global, Prefilled Syringe Fill / Finish Capacity: Distribution by Company Size of Manufacturer (in Million Liters)
• Table 18.28 Global, Prefilled Syringe Fill / Finish Capacity (by Volume): Distribution by Scale of Operation (in Million Liters)
• Table 18.29 Global, Prefilled Syringe Fill / Finish Capacity (by Volume): Distribution by Location of Headquarters (in Million Liters)
• Table 18.30 Global, Prefilled Syringe Fill / Finish Capacity (by Volume): Distribution by Location of Fill / Finish Facilities (in Million Liters)
• Table 18.31 Global, Prefilled Syringe Fill / Finish Capacity (by Volume): Distribution by Type of Drug Molecule (in Million Liters)
• Table 18.32 Global, Demand for Prefilled Syringe Fill / Finish Services
• Table 18.33 Global, Demand for Prefilled Syringe Fill / Finish Services: Distribution by Geography
• Table 18.34 Global, Demand for Prefilled Syringe Fill / Finish Services: Distribution by Type of Drug Molecule
• Table 18.35 Global, Demand for Prefilled Syringe Fill / Finish Services: Distribution by Therapeutic Area
• Table 18.36 Global, Demand for Prefilled Syringe Fill / Finish Services: Distribution by Syringe Barrel Material
• Table 18.37 Global, Demand for Prefilled Syringe Fill / Finish Services: Distribution by Number of Barrel Chambers
• Table 18.38 Demand and Supply Assessment: North America
• Table 18.39 Demand and Supply Assessment: Europe
• Table 18.40 Demand and Supply Assessment: Asia-Pacific and Rest of the World
• Table 18.41 Likely Partner Analysis: Distribution by Geography
• Table 18.42 Overall Prefilled Syringe Fill / Finish Services Market, Conservative, Base and Optimistic Scenarios, Till 2035 (USD Billion)
• Table 18.43 Prefilled Syringe Fill / Finish Services Market, Till 2035: Distribution by Scale of Operation, Conservative, Base and Optimistic Scenarios, (USD Million)
• Table 18.44 Prefilled Syringe Fill / Finish Services Market, Till 2035: Distribution by Geographical Location, Conservative, Base and Optimistic Scenarios, (USD Million)
• Table 18.45 Prefilled Syringe Fill / Finish Services Market, Till 2035: Distribution by Type of Drug Molecule, Conservative, Base and Optimistic Scenarios, (USD Million)
• Table 18.46 Prefilled Syringe Fill / Finish Services Market, Till 2035: Distribution by Therapeutic Area, Conservative, Base and Optimistic Scenarios, (USD Million)
• Table 18.47 Prefilled Syringe Fill / Finish Services Market, Till 2035: Distribution by Syringe Barrel Material, Conservative, Base and Optimistic Scenarios, (USD Million)
• Table 18.48 Prefilled Syringe Fill / Finish Services Market, Till 2035: Distribution by Number of Barrel Chambers, Conservative, Base and Optimistic Scenarios, (USD Million)
• Table 18.49 Prefilled Syringes: Distribution by Syringe Barrel Material
• Table 18.50 Prefilled Syringes: Distribution by Number of Barrel Chambers
• Table 18.51 Prefilled Syringes: Distribution by Type of Needle System
• Table 18.52 Prefilled Syringes: Distribution by Barrel Volume
• Table 18.53 Prefilled Syringe Manufacturers: Distribution by Year of Establishment
• Table 18.54 Prefilled Syringe Manufacturers: Distribution by Company Size
• Table 18.55 Prefilled Syringe Manufacturers: Distribution by Location of Headquarters

List of Figures

• Figure 3.1 Prefilled Syringe Manufacturing: Common Processes
• Figure 3.2 Prefilled Syringes: Fill / Finish Process
• Figure 3.3 Risks and Challenges of Outsourcing Fill / Finish Operations
• Figure 3.4 Key Considerations while Selecting a Fill / Finish Service Provider
• Figure 4.1 Prefilled Syringe Fill / Finish Service Providers: Distribution by Year of Establishment
• Figure 4.2 Prefilled Syringe Fill / Finish Service Providers: Distribution by Company Size
• Figure 4.3 Prefilled Syringe Fill / Finish Service Providers: Distribution by Scale of Operation
• Figure 4.4 Prefilled Syringe Fill / Finish Service Providers: Distribution by Location of Headquarters
• Figure 4.5 Prefilled Syringe Fill / Finish Service Providers: Distribution by Location of Prefilled Syringe Fill / Finish Facilities
• Figure 4.6 Prefilled Syringe Fill / Finish Service Providers: Distribution by Type of Drug Molecule
• Figure 4.7 Prefilled Syringe Fill / Finish Service Providers: Distribution by Syringe Barrel Material
• Figure 4.8 Prefilled Syringe Fill / Finish Service Providers: Distribution by Syringe Fill Volume
• Figure 4.9 Prefilled Syringe Fill / Finish Service Providers: Distribution by Additional Services Offered
• Figure 4.10 Prefilled Syringe Fill / Finish Service Providers: Distribution by Company Size and Type of Drug Molecule
• Figure 4.11 Prefilled Syringe Fill / Finish Service Providers: Distribution by Scale of Operation and Location of Fill / Finish Facilities
• Figure 4.12 Prefilled Syringe Fill / Finish Service Providers: Distribution by Year of Establishment, Company Size and Type of Drug Molecule
• Figure 8.1 Expansions: Distribution by Year of Expansion, Since 2015
• Figure 8.2 Expansions: Distribution by Type of Expansion
• Figure 8.3 Expansions: Distribution by Expanded Scale of Operation
• Figure 8.4 Expansions: Distribution by Location of Expansion Project
• Figure 8.5 Expansions: Distribution by Type of Drug Molecule Involved
• Figure 8.6 Expansions: Distribution by Additional Services Offered (Expansion Specific)
• Figure 8.7 Partnerships and Collaborations: Cumulative Trend by Year, Since 2015
• Figure 8.8 Partnerships and Collaborations: Distribution by Type of Partnership
• Figure 8.9 Partnerships and Collaborations: Distribution by Scale of Operation (Deal Specific)
• Figure 8.10 Partnerships and Collaborations: Distribution by Additional Services Offered (Deal Specific)
• Figure 9.1 Global, Prefilled Syringe Fill / Finish Capacity: Distribution of Capacity by Company Size (Sample Data Set)
• Figure 9.2 Global, Prefilled Syringe Fill / Finish Capacity: Distribution by Company Size (in Million Units)
• Figure 9.3 Global, Prefilled Syringe Fill / Finish Capacity (by Number of Units): Distribution by Scale of Operation (in Million Units)
• Figure 9.4 Global, Prefilled Syringe Fill / Finish Capacity (by Number of Units): Distribution by Location of Headquarters (in Million Units)
• Figure 9.5 Global, Prefilled Syringe Fill / Finish Capacity (by Number of Units): Distribution by Location of Fill / Finish Facilities (in Million Units)
• Figure 9.6 Global, Prefilled Syringe Fill / Finish Capacity (by Number of Units): Distribution by Type of Drug Molecule (in Million Units)
• Figure 9.7 Global, Prefilled Syringe Fill / Finish Capacity: Distribution by Company Size (in Million Liters)
• Figure 9.8 Global, Prefilled Syringe Fill / Finish Capacity (by Volume): Distribution by Scale of Operation (in Million Liters)
• Figure 9.9 Global, Prefilled Syringe Fill / Finish Capacity (by Volume): Distribution by Location of Headquarters (in Million Liters)
• Figure 9.10 Global, Prefilled Syringe Fill / Finish Capacity (by Volume): Distribution by Location of Fill / Finish Facilities (in Million Liters)
• Figure 9.11 Global, Prefilled Syringe Fill / Finish Capacity (by Volume): Distribution by Type of Drug Molecule (in Million Liters)
• Figure 10.1 Global, Demand for Prefilled Syringe Fill / Finish Services
• Figure 10.2 Global, Demand for Commercialized Prefilled Syringe Fill / Finish Services
• Figure 10.3 Global, Demand for Prefilled Syringe Fill / Finish Services: Share of North America
• Figure 10.4 Global, Demand for Prefilled Syringe Fill / Finish Services: Share of Europe
• Figure 10.5 Global, Demand for Prefilled Syringe Fill / Finish Services: Share of Asia-Pacific
• Figure 10.6 Global, Demand for Prefilled Syringe Fill / Finish Services: Share of Latin America
• Figure 10.7 Global, Demand for Prefilled Syringe Fill / Finish Services: Share of Middle East and Africa
• Figure 10.8 Global, Demand for Prefilled Syringe Fill / Finish Services: Distribution by Syringe Barrel Material
• Figure 10.9 Global, Demand for Prefilled Syringe Fill / Finish Services: Distribution by Number of Barrel Chambers
• Figure 10.10 Global, Demand for Prefilled Syringe Fill / Finish Services: Distribution by Type of Drug Molecule
• Figure 10.11 Global, Demand for Prefilled Syringe Fill / Finish Services: Distribution by Therapeutic Area
• Figure 10.12 Global, Demand for Prefilled Syringe Fill / Finish Services: Distribution by Specialty Syringes
• Figure 10.13 Global, Demand for Clinical Prefilled Syringe Fill / Finish Services
• Figure 10.14 Global, Prefilled Syringe Fill / Finish Services: Demand and Supply Dynamics (Scenario 1)
• Figure 10.15 Global, Prefilled Syringe Fill / Finish Services: Demand and Supply Dynamics (Scenario 2)
• Figure 10.16 Global, Prefilled Syringe Fill / Finish Services: Demand and Supply Dynamics (Scenario 3)
• Figure 11.1 Demand and Supply Assessment: North America
• Figure 11.2 Demand and Supply Assessment: US
• Figure 11.3 Demand and Supply Assessment: Europe
• Figure 11.4 Demand and Supply Assessment: France
• Figure 11.5 Demand and Supply Assessment: Germany
• Figure 11.6 Demand and Supply Assessment: Italy
• Figure 11.7 Demand and Supply Assessment: Asia-Pacific Region
• Figure 11.8 Demand and Supply Assessment: India
• Figure 11.9 Demand and Supply Assessment: Japan
• Figure 12.1 Likely Partner Analysis: Distribution by Company Size and Location of Headquarters
• Figure 13.1 Overall Prefilled Syringe Fill / Finish Services Market, Till 2035 (USD Billion)
• Figure 13.2 Prefilled Syringe Fill / Finish Services Market, Till 2035: Distribution by Scale of Operation (USD Million)
• Figure 13.3 Prefilled Syringe Fill / Finish Services Market: Distribution by Geographical Location (USD Million)
• Figure 13.4 Prefilled Syringe Fill / Finish Services Market, Till 2035: Distribution by Geographical Location, North America (USD Million)
• Figure 13.5 Prefilled Syringe Fill / Finish Services Market, Till 2035: Distribution by Geographical Location, Europe (USD Million)
• Figure 13.6 Prefilled Syringe Fill / Finish Services Market, Till 2035: Distribution by Geographical Location, Asia-Pacific (USD Million)
• Figure 13.7 Prefilled Syringe Fill / Finish Services Market, Till 2035: Distribution by Geographical Location, Latin America (USD Million)
• Figure 13.8 Prefilled Syringe Fill / Finish Services Market, Till 2035: Distribution by Geographical Location, Middle East and Africa (USD Million)
• Figure 13.9 Prefilled Syringe Fill / Finish Services Market, Till 2035: Distribution by Type of Drug Molecule (USD Million)
• Figure 13.10 Prefilled Syringe Fill / Finish Services Market: Distribution by Therapeutic Area (USD Million)
• Figure 13.11 Prefilled Syringe Fill / Finish Services Market, Till 2035: Distribution by Syringe Barrel Material (USD Million)
• Figure 13.12 Prefilled Syringe Fill / Finish Services Market, Till 2035: Distribution by Number of Barrel Chambers (USD Million)
• Figure 14.1 Growth Opportunities for Prefilled Syringe Fill / Finish Service Providers
• Figure 14.2 Pipeline Distribution by Route of Administration
• Figure 14.3 FDA Approved Biologics and Biosimilars, Since 2014
• Figure 14.4 Approved Prefilled Syringe Combination Products: Cumulative Distribution by Approval Year
• Figure 14.5 Clinical Stage Prefilled Syringes Combination Products: Distribution by Phase of Development
• Figure 15.1 Prefilled Syringes: Distribution by Syringe Barrel Material
• Figure 15.2 Prefilled Syringes: Distribution by Number of Barrel Chambers
• Figure 15.3 Prefilled Syringes: Distribution by Type of Needle System
• Figure 15.4 Prefilled Syringes: Distribution by Barrel Volume
• Figure 15.5 Prefilled Syringe Developers: Distribution by Year of Establishment
• Figure 15.6 Prefilled Syringe Developers: Distribution by Location of Headquarters